scholarly journals Metastatic Castration-Resistant Prostate Cancer with Neuroendocrine Transformation and BRCA 1 Germ-Line Mutation: A Case Report and Literature Review

2020 ◽  
Vol Volume 13 ◽  
pp. 8049-8054 ◽  
Author(s):  
Yinhang Wu ◽  
Yongsheng Gao ◽  
Xue Dou ◽  
Jinbo Yue
Keyword(s):  
Prostate Cancer ◽  
Case Report ◽  
Literature Review ◽  
Germ Line ◽  
Castration Resistant Prostate Cancer ◽  
Castration Resistant ◽  
Brca 1 ◽  
Germ Line Mutation

Prostate-Specific Antigen Flare Phenomenon During 223Ra-Dichloride Treatment for Bone Metastatic Castration-Resistant Prostate Cancer: A Case Report

2016 ◽  
Vol 14 (5) ◽  
pp. e529-e533 ◽  
Author(s):  
Giuseppe De Vincentis ◽  
Giulia Anna Follacchio ◽  
Viviana Frantellizzi ◽  
Mauro Liberatore ◽  
Francesco Monteleone ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Case Report ◽  
Prostate Specific Antigen ◽  
Specific Antigen ◽  
Castration Resistant Prostate Cancer ◽  
Flare Phenomenon ◽  
Castration Resistant

Tumor Lysis Syndrome After Platinum-based Chemotherapy in Castration-resistant Prostate Cancer With a BRCA2 Mutation: A Case Report

2019 ◽  
Vol 17 (1) ◽  
pp. e61-e64 ◽  
Author(s):  
Aline Bobato Lara Gongora ◽  
Felipe Sales Nogueira Amorim Canedo ◽  
André Luis Alves de Melo ◽  
Regis Otaviano Franca Bezerra ◽  
Paula Fontes Asprino ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Case Report ◽  
Brca2 Mutation ◽  
Tumor Lysis Syndrome ◽  
Castration Resistant Prostate Cancer ◽  
Tumor Lysis ◽  
Castration Resistant ◽  
Platinum Based Chemotherapy

Optic atrophy after cabazitaxel treatment in a patient with castration-resistant prostate cancer: a case report

2018 ◽  
Vol 64 (2) ◽  
pp. 71-73 ◽  
Author(s):  
Sevda Diker ◽  
Ömer Diker
Keyword(s):  
Prostate Cancer ◽  
Drug Resistance ◽  
Case Report ◽  
Adverse Effects ◽  
Optic Neuropathy ◽  
Optic Atrophy ◽  
Castration Resistant Prostate Cancer ◽  
Castration Resistant ◽  
Anti Cancer ◽  
New Generation

Taxanes are a group of cytotoxic anti-cancer agents used in the treatment of solid tumours. The neurotoxic adverse effects of docetaxel and paclitaxel, including optic neuropathy, are well known. Cabazitaxel is a new generation taxane showing lesser drug resistance when compared with previous ones. Optic atrophy due to the use of cabazitaxel has not been previously reported. Herein, we report a patient with prostate cancer who developed optic atrophy after cabazitaxel treatment.

Metastatic castration-resistant prostate cancer (mCRPC) treated with 225Ac-PSMA-617. Case report

2019 ◽  
Author(s):  
Rodrigo Bovolin de Medeiros ◽  
Marcus Vinicius Grigolon ◽  
Tatianny Paula Araújo ◽  
Miguel Srougi
Keyword(s):  
Prostate Cancer ◽  
Case Report ◽  
Castration Resistant Prostate Cancer ◽  
Castration Resistant
Sign in / Sign up

Export Citation Format

Share Document